查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
冠狀動脈支架市場:各類型，各生物材料，各終端用戶:全球機會分析及產業預測，2020年～2030年
市場調查報告書
商品編碼
1090847

冠狀動脈支架市場:各類型，各生物材料，各終端用戶:全球機會分析及產業預測，2020年～2030年

Coronary Stents Market By Type, By Biomaterial, By End User : Global Opportunity Analysis and Industry Forecast, 2020-2030
出版日期: | 出版商: Allied Market Research | 英文 236 Pages | 商品交期: 2-3個工作天內

價格

全球冠狀動脈支架的市場規模在2020年估算為88億1,490萬美金。

該市場在2021年～2030年預計將以6.0％的年複合成長率擴大，到2030年達到154億2,106萬美元。

本報告提供全球冠狀動脈支架市場相關調查，提供市場概要，以及各類型，各生物材料，各終端用戶，各地區的趨勢，及加入此市場的主要企業簡介等資訊。

目錄

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義和範圍
  • 主要調查結果
  • 波特的五力分析
  • 主要加入企業的地位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 市場上COVID-19影響分析

第4章 冠狀動脈支架市場:各類型

  • 概要
    • 市場規模與預測
  • 藥物釋放型性支架
  • 裸機冠狀動脈支架
  • 生物可吸收支架

第5章 冠狀動脈支架市場:各生物材料

  • 概要
    • 市場規模與預測
  • 金屬生物材料
  • 聚合物生物材料
  • 天然生物材料

第6章 冠狀動脈支架市場:各終端用戶

  • 概要
    • 市場規模與預測
  • 醫院
  • 門診病人手術中心
  • 其他

第7章 冠狀動脈支架市場:各地區

  • 概要
    • 市場規模與預測
  • 北美
  • 歐洲
  • 亞太地區
  • 南美·中東·非洲

第8章 企業的形勢

  • 簡介
  • 主要的成功策略
  • 10家主要企業的產品製圖
  • 競爭力儀表板
  • 競爭力熱圖
  • 主要的發展

第9章 企業簡介

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik Se & Co. KG
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Elixir Medical Corporation
  • Medtronic PLC.
  • Microport Scientific Corporation
  • Biosensors International Group
  • Terumo Corporation
Product Code: A01857

The global coronary stents market was valued at $8,814.9 million in 2020 and is projected to reach $15,421.06 million by 2030, registering a CAGR of 6.0% from 2021 to 2030.

Coronary stent is a  small expandable tube, which is used for the treatment of narrowed or blocked coronary arteries and reduce chest pain (angina). Patients with coronary artery disease (CAD) are treated using these stents. These stents are also known as cardiac stents and comprise metallic mesh. These coronary stents are implanted in narrowed coronary artery during percutaneous coronary intervention (PCI).

The factor that drives growth of coronary stents market include increase in incidence of CAD, rise in innovation in coronary stents, and surge in improved clinical outcomes, due to stenting.

In addition, rise in incidence of chronic & lifestyle diseases, especially diabetes and obesity and improved insurance & reimbursement scenario supplement the global coronary stents market growth.

Conversely, availability of alternative methods for coronary heart disease treatment and high cost of treatment associated with coronary stents hinder the growth of the market during forecast years. However, increase in adoption of coronary stents in developing countries is expected to offer lucrative growth opportunities for the market during the forecast period.

The global coronary stents market is segmented on the basis of product, biomaterial, end user, and region. Depending on product, it is classified into drug-eluting stent, bare-metal stent, and bioabsorbable vascular stent. On the basis of biomaterial, it is categorized into metallic, polymeric, and natural biomaterial. According to end user, it is divided into hospitals, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key market players profiled in the report include: Abbott Laboratories, B. Braun Melsungen AG, Boston Scientific Corporation, Becton Dickinson and Company, Microport Scientific Corporation, Terumo Corporation, Medtronic plc., Biotronik SE & Co. KG, Biosensors International Group, Ltd., and Elixir Medical Corporation.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coronary stents market analysis from 2020 to 2030 to identify the prevailing coronary stents market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the coronary stents market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global coronary stents market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Drug-eluting Stents
  • Bare-metal Coronary Stents
  • Bioabsorbable Stents

By Biomaterial

  • Metallic biomaterials
  • Polymers biomaterials
  • Natural biomaterials

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Other

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of LAMEA
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of LAMEA
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • B. Braun Melsungen AG
    • Biotronik Se & Co. KG
    • Boston Scientific Corporation
    • Becton, Dickinson and Company
    • Elixir Medical Corporation
    • Medtronic PLC.
    • Microport Scientific Corporation
    • Biosensors International Group
    • Terumo Corporation

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CORONARY STENTS MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Drug-eluting Stents
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Bare-metal Coronary Stents
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Bioabsorbable Stents
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: CORONARY STENTS MARKET, BY BIOMATERIAL

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Metallic biomaterials
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Polymers biomaterials
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Natural biomaterials
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CORONARY STENTS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Ambulatory Surgical Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country
  • 6.4 Other
    • 6.4.1 Key market trends, growth factors and opportunities
    • 6.4.2 Market size and forecast, by region
    • 6.4.3 Market analysis by country

CHAPTER 7: CORONARY STENTS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Biomaterial
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Biomaterial
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Biomaterial
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Biomaterial
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Biomaterial
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Biomaterial
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Biomaterial
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 U.K.
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Biomaterial
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Biomaterial
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Biomaterial
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of LAMEA
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Biomaterial
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Biomaterial
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Biomaterial
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Biomaterial
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Biomaterial
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Biomaterial
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 South Korea
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Biomaterial
      • 7.4.5.5.3 Market size and forecast, by End User
      • 7.4.5.6 Rest of LAMEA
      • 7.4.5.6.1 Market size and forecast, by Type
      • 7.4.5.6.2 Market size and forecast, by Biomaterial
      • 7.4.5.6.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Biomaterial
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Biomaterial
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Biomaterial
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Biomaterial
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Biomaterial
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbott Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 B. Braun Melsungen AG
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Biotronik Se & Co. KG
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Boston Scientific Corporation
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Becton, Dickinson and Company
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Elixir Medical Corporation
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Medtronic PLC.
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Microport Scientific Corporation
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Biosensors International Group
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Terumo Corporation
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments

LIST OF TABLES

  • TABLE 1. GLOBAL CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
  • TABLE 2. CORONARY STENTS MARKET REVENUE, FOR DRUG-ELUTING STENTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 3. CORONARY STENTS MARKET DRUG-ELUTING STENTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 4. CORONARY STENTS MARKET REVENUE, FOR BARE-METAL CORONARY STENTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 5. CORONARY STENTS MARKET BARE-METAL CORONARY STENTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 6. CORONARY STENTS MARKET REVENUE, FOR BIOABSORBABLE STENTS, BY REGION , 2020-2030,($MILLION)
  • TABLE 7. CORONARY STENTS MARKET BIOABSORBABLE STENTS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 8. GLOBAL CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
  • TABLE 9. CORONARY STENTS MARKET REVENUE, FOR METALLIC BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
  • TABLE 10. CORONARY STENTS MARKET METALLIC BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 11. CORONARY STENTS MARKET REVENUE, FOR POLYMERS BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
  • TABLE 12. CORONARY STENTS MARKET POLYMERS BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 13. CORONARY STENTS MARKET REVENUE, FOR NATURAL BIOMATERIALS, BY REGION , 2020-2030,($MILLION)
  • TABLE 14. CORONARY STENTS MARKET NATURAL BIOMATERIALS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 15. GLOBAL CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 16. CORONARY STENTS MARKET REVENUE, FOR HOSPITALS, BY REGION , 2020-2030,($MILLION)
  • TABLE 17. CORONARY STENTS MARKET HOSPITALS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 18. CORONARY STENTS MARKET REVENUE, FOR AMBULATORY SURGICAL CENTERS, BY REGION , 2020-2030,($MILLION)
  • TABLE 19. CORONARY STENTS MARKET AMBULATORY SURGICAL CENTERS BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 20. CORONARY STENTS MARKET REVENUE, FOR OTHER, BY REGION , 2020-2030,($MILLION)
  • TABLE 21. CORONARY STENTS MARKET OTHER BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 22. CORONARY STENTS MARKET, BY REGION, 2020-2030,($MILLION)
  • TABLE 23. NORTH AMERICA CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
  • TABLE 24. NORTH AMERICA CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
  • TABLE 25. NORTH AMERICA CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 26. NORTH AMERICA CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 27. U.S. CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 28. U.S. CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 29. U.S. CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 30. CANADA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 31. CANADA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 32. CANADA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 33. MEXICO CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 34. MEXICO CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 35. MEXICO CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 36. EUROPE CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
  • TABLE 37. EUROPE CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
  • TABLE 38. EUROPE CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 39. EUROPE CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 40. GERMANY CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 41. GERMANY CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 42. GERMANY CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 43. FRANCE CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 44. FRANCE CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 45. FRANCE CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 46. U.K. CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 47. U.K. CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 48. U.K. CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 49. ITALY CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 50. ITALY CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 51. ITALY CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 52. SPAIN CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 53. SPAIN CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 54. SPAIN CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 55. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 56. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 57. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 58. ASIA-PACIFIC CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
  • TABLE 59. ASIA-PACIFIC CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
  • TABLE 60. ASIA-PACIFIC CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 61. ASIA-PACIFIC CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 62. CHINA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 63. CHINA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 64. CHINA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 65. JAPAN CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 66. JAPAN CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 67. JAPAN CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 68. INDIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 69. INDIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 70. INDIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 71. AUSTRALIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 72. AUSTRALIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 73. AUSTRALIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 74. SOUTH KOREA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 75. SOUTH KOREA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 76. SOUTH KOREA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 77. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 78. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 79. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 80. LAMEA CORONARY STENTS MARKET, BY TYPE, 2020-2030,($MILLION)
  • TABLE 81. LAMEA CORONARY STENTS MARKET, BY BIOMATERIAL, 2020-2030,($MILLION)
  • TABLE 82. LAMEA CORONARY STENTS MARKET, BY END USER, 2020-2030,($MILLION)
  • TABLE 83. LAMEA CORONARY STENTS MARKET, BY COUNTRY, 2020-2030,($MILLION)
  • TABLE 84. BRAZIL CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 85. BRAZIL CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 86. BRAZIL CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 87. SAUDI ARABIA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 88. SAUDI ARABIA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 89. SAUDI ARABIA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 90. SOUTH AFRICA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 91. SOUTH AFRICA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 92. SOUTH AFRICA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 93. REST OF LAMEA CORONARY STENTS MARKET BY TYPE 2020-2030,($MILLION)
  • TABLE 94. REST OF LAMEA CORONARY STENTS MARKET BY BIOMATERIAL 2020-2030,($MILLION)
  • TABLE 95. REST OF LAMEA CORONARY STENTS MARKET BY END USER 2020-2030,($MILLION)
  • TABLE 96.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 97.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 98.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 99.ABBOTT LABORATORIES: NET SALES,
  • TABLE 100.ABBOTT LABORATORIES: KEY STRATERGIES
  • TABLE 101.B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
  • TABLE 102.B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
  • TABLE 103.B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
  • TABLE 104.B. BRAUN MELSUNGEN AG: NET SALES,
  • TABLE 105.B. BRAUN MELSUNGEN AG: KEY STRATERGIES
  • TABLE 106.BIOTRONIK SE & CO. KG: COMPANY SNAPSHOT
  • TABLE 107.BIOTRONIK SE & CO. KG: OPERATING SEGMENTS
  • TABLE 108.BIOTRONIK SE & CO. KG: PRODUCT PORTFOLIO
  • TABLE 109.BIOTRONIK SE & CO. KG: NET SALES,
  • TABLE 110.BIOTRONIK SE & CO. KG: KEY STRATERGIES
  • TABLE 111.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 112.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 113.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 114.BOSTON SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 115.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 116.BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • TABLE 117.BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
  • TABLE 118.BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
  • TABLE 119.BECTON, DICKINSON AND COMPANY: NET SALES,
  • TABLE 120.BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
  • TABLE 121.ELIXIR MEDICAL CORPORATION: COMPANY SNAPSHOT
  • TABLE 122.ELIXIR MEDICAL CORPORATION: OPERATING SEGMENTS
  • TABLE 123.ELIXIR MEDICAL CORPORATION: PRODUCT PORTFOLIO
  • TABLE 124.ELIXIR MEDICAL CORPORATION: NET SALES,
  • TABLE 125.ELIXIR MEDICAL CORPORATION: KEY STRATERGIES
  • TABLE 126.MEDTRONIC PLC.: COMPANY SNAPSHOT
  • TABLE 127.MEDTRONIC PLC.: OPERATING SEGMENTS
  • TABLE 128.MEDTRONIC PLC.: PRODUCT PORTFOLIO
  • TABLE 129.MEDTRONIC PLC.: NET SALES,
  • TABLE 130.MEDTRONIC PLC.: KEY STRATERGIES
  • TABLE 131.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
  • TABLE 132.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
  • TABLE 133.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
  • TABLE 134.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
  • TABLE 135.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
  • TABLE 136.BIOSENSORS INTERNATIONAL GROUP: COMPANY SNAPSHOT
  • TABLE 137.BIOSENSORS INTERNATIONAL GROUP: OPERATING SEGMENTS
  • TABLE 138.BIOSENSORS INTERNATIONAL GROUP: PRODUCT PORTFOLIO
  • TABLE 139.BIOSENSORS INTERNATIONAL GROUP: NET SALES,
  • TABLE 140.BIOSENSORS INTERNATIONAL GROUP: KEY STRATERGIES
  • TABLE 141.TERUMO CORPORATION: COMPANY SNAPSHOT
  • TABLE 142.TERUMO CORPORATION: OPERATING SEGMENTS
  • TABLE 143.TERUMO CORPORATION: PRODUCT PORTFOLIO
  • TABLE 144.TERUMO CORPORATION: NET SALES,
  • TABLE 145.TERUMO CORPORATION: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CORONARY STENTS MARKET SEGMENTATION
  • FIGURE 2.CORONARY STENTS MARKET,2020-2030
  • FIGURE 3.CORONARY STENTS MARKET,2020-2030
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CORONARY STENTS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11.CORONARY STENTS MARKET,BY TYPE,2020(%)
  • FIGURE 12.COMPARATIVE SHARE ANALYSIS OF DRUG-ELUTING STENTS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF BARE-METAL CORONARY STENTS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF BIOABSORBABLE STENTS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 15.CORONARY STENTS MARKET,BY BIOMATERIAL,2020(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF METALLIC BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF POLYMERS BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF NATURAL BIOMATERIALS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 19.CORONARY STENTS MARKET,BY END USER,2020(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 22.COMPARATIVE SHARE ANALYSIS OF OTHER CORONARY STENTS MARKET,2020-2030(%)
  • FIGURE 23.CORONARY STENTS MARKET BY REGION,2020
  • FIGURE 24.U.S. CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 25.CANADA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 26.MEXICO CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 27.GERMANY CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 28.FRANCE CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 29.U.K. CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 30.ITALY CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 31.SPAIN CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 32.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 33.CHINA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 34.JAPAN CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 35.INDIA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 36.AUSTRALIA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 37.SOUTH KOREA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 38.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 39.BRAZIL CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 40.SAUDI ARABIA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 41.SOUTH AFRICA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 42.REST OF LAMEA CORONARY STENTS MARKET,2020-2030($MILLION)
  • FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 46.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 47.COMPETITIVE DASHBOARD
  • FIGURE 48.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 49.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
  • FIGURE 50.B. BRAUN MELSUNGEN AG.: NET SALES ,($MILLION)
  • FIGURE 51.BIOTRONIK SE & CO. KG.: NET SALES ,($MILLION)
  • FIGURE 52.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 53.BECTON, DICKINSON AND COMPANY.: NET SALES ,($MILLION)
  • FIGURE 54.ELIXIR MEDICAL CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 55.MEDTRONIC PLC..: NET SALES ,($MILLION)
  • FIGURE 56.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 57.BIOSENSORS INTERNATIONAL GROUP.: NET SALES ,($MILLION)
  • FIGURE 58.TERUMO CORPORATION.: NET SALES ,($MILLION)